financetom
Business
financetom
/
Business
/
Capgemini expects annual revenue to fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Capgemini expects annual revenue to fall
Jul 25, 2024 10:23 PM

(Reuters) - French IT consulting group Capgemini said on Friday it now expects its annual revenue to fall compared with the earlier expectation of a rise, citing weakness in the North America market.

The Paris-based group said it now expects its organic sales to fall between 0.5% and 1.5%, compared with a 0-3% rise previously forecast.

"The slope of recovery in the second half will be affected by the recent deterioration of the outlook in the automotive and aerospace sectors and the slower recovery in financial services," CEO Aiman Ezzat said in a statement.

The group confirmed its 2024 operating margin and organic free cash flow targets.

(Reporting by Dimitri Rhodes and Leo Marchandon; Editing by Subhranshu Sahu)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Hutchmed New Drug Application for Lung Cancer Combination Treatment Approved in China
Hutchmed New Drug Application for Lung Cancer Combination Treatment Approved in China
Jun 30, 2025
05:18 AM EDT, 06/30/2025 (MT Newswires) -- Hutchmed ( HCM ) said Monday that the China National Medical Products Administration has approved its new drug application for the combination of Orpathys and Tagrisso to treat a certain type of lung cancer. The approval covers locally advanced or metastatic epidermal growth factor receptor mutation-positive non-squamous non-small cell lung cancer with MET...
UK competition watchdog begins initial probe into Boeing-Spirit Aero deal
UK competition watchdog begins initial probe into Boeing-Spirit Aero deal
Jun 30, 2025
June 30 (Reuters) - Britain's competition regulator said on Monday it has begun a Phase 1 investigation into planemaker Boeing's ( BA ) deal to acquire Spirit Aerosystems ( SPR ) and set a deadline of August 28 for a decision. The Competition and Markets Authority (CMA) had said last week that it was weighing a probe into whether the...
Analysis-Chinese money fires up Hong Kong shares
Analysis-Chinese money fires up Hong Kong shares
Jun 30, 2025
SHANGHAI/HONG KONG (Reuters) -Chinese investors are piling into Hong Kong shares lured by lower valuations and the city's strategic position in China's growing rivalry with the United States. A record $90 billion of cash from the mainland has driven a stellar 21% rally in Hong Kong stocks in the first half of 2025, reshaping the landscape of a market foreign...
Copyright 2023-2026 - www.financetom.com All Rights Reserved